The National Agency for the Control of HIV/AIDS (NACA) has revealed that seven hundred and forty-seven thousand, eight hundred and fifty-three females are among the 1,090,233 people on Anti-Retroviral (ARV) treatment in Nigeria by June, 2018.
This puts the percentage of females living with HIV at 68.5% of the total.
In a statement to News Agency of Nigeria (NAN) in Abuja on Friday, Mr
Greg Ashefor, the Acting Director, Research Monitoring and Evaluation Directorate, in Abuja on Friday,
added that 342, 380 males were also on ARV treatment.
He said the number included all persons on treatment programmes supported by the U.S Government (PEPFAR), Global Fund, and the Federal Government.
Ashefor further said that the Federal Government programme covered 62, 120 persons on treatment, with 44,116 persons in Taraba and 17,904 persons in Abia.
Earlier, in an interview, Ashefor had said that the Federal Government was planning to include an additional 50,000 people from Taraba and Abia to receive treatment.
According to him, about 76,000 people are currently on treatment in Taraba and Abia for which the government is solely responsible.
“The government has a scale-up plan, called fast-track plan to actually put more people on drugs.
“There are other interventions going on. The partners are also doing test and treatment in collaboration with the government.
Ashefor said, however, that there was still a huge gap in terms of data management.